| Primary |
| Epilepsy |
61.4% |
| Petit Mal Epilepsy |
14.0% |
| Convulsion |
7.0% |
| Myoclonic Epilepsy |
7.0% |
| Absence Seizure |
1.8% |
| Asthma |
1.8% |
| Grand Mal Convulsion |
1.8% |
| Hypothyroidism |
1.8% |
| Liver Disorder |
1.8% |
| Status Epilepticus |
1.8% |
|
| Product Substitution Issue |
10.7% |
| Amnesia |
7.1% |
| Benign Rolandic Epilepsy |
7.1% |
| Pharmaceutical Product Complaint |
7.1% |
| Pseudolymphoma |
7.1% |
| Pyloric Stenosis |
7.1% |
| Sleep Terror |
7.1% |
| Abortion Spontaneous |
3.6% |
| Autism |
3.6% |
| Bone Marrow Transplant |
3.6% |
| Central Nervous System Lesion |
3.6% |
| Dizziness |
3.6% |
| Drug Effect Decreased |
3.6% |
| Drug Ineffective |
3.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.6% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
3.6% |
| Dyspnoea |
3.6% |
| Hallucination, Visual |
3.6% |
| Heart Rate Irregular |
3.6% |
| Hepatic Adenoma |
3.6% |
|
| Secondary |
| Epilepsy |
37.3% |
| Convulsion |
20.7% |
| Partial Seizures |
6.3% |
| Foetal Exposure During Pregnancy |
5.3% |
| Myoclonic Epilepsy |
5.0% |
| Status Epilepticus |
5.0% |
| Mental Retardation |
4.4% |
| Petit Mal Epilepsy |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Drug Use For Unknown Indication |
2.5% |
| Amnesia |
1.9% |
| Klebsiella Infection |
0.9% |
| Lennox-gastaut Syndrome |
0.9% |
| Bipolar Disorder |
0.6% |
| Hypoxia |
0.6% |
| Maternal Exposure Timing Unspecified |
0.6% |
| Panic Attack |
0.6% |
| Angioedema |
0.3% |
| Depressed Level Of Consciousness |
0.3% |
| Grand Mal Convulsion |
0.3% |
|
| Sweat Gland Disorder |
19.6% |
| Hepatic Adenoma |
9.8% |
| Pyloric Stenosis |
9.8% |
| Convulsion |
7.8% |
| Systemic Lupus Erythematosus |
5.9% |
| Blister |
3.9% |
| Coma Blister |
3.9% |
| Congenital Cardiovascular Anomaly |
3.9% |
| Drug Ineffective For Unapproved Indication |
3.9% |
| Exposure During Pregnancy |
3.9% |
| Irritability |
3.9% |
| Paraesthesia |
3.9% |
| Petit Mal Epilepsy |
3.9% |
| Urticaria |
3.9% |
| Amnesia |
2.0% |
| Coma |
2.0% |
| Congenital Anomaly |
2.0% |
| Dystonia |
2.0% |
| Foetal Exposure During Pregnancy |
2.0% |
| Hypoglycaemia |
2.0% |
|
| Concomitant |
| Epilepsy |
53.1% |
| Product Used For Unknown Indication |
8.6% |
| Lennox-gastaut Syndrome |
7.1% |
| Convulsion |
6.5% |
| Infantile Spasms |
6.5% |
| Drug Use For Unknown Indication |
4.5% |
| Petit Mal Epilepsy |
3.5% |
| Myoclonic Epilepsy |
3.0% |
| Asthma |
1.3% |
| Pyrexia |
1.0% |
| Antibiotic Prophylaxis |
0.7% |
| Grand Mal Convulsion |
0.7% |
| Hypersensitivity |
0.7% |
| Abnormal Behaviour |
0.5% |
| Partial Seizures |
0.5% |
| Psychotic Disorder |
0.5% |
| Schizophrenia |
0.5% |
| Anxiety |
0.3% |
| Idiopathic Thrombocytopenic Purpura |
0.3% |
| Niemann-pick Disease |
0.3% |
|
| Petit Mal Epilepsy |
13.8% |
| Tracheo-oesophageal Fistula |
13.8% |
| Vesicoureteric Reflux |
10.6% |
| Drug Ineffective |
7.4% |
| Vomiting |
6.4% |
| Convulsion |
5.3% |
| Grand Mal Convulsion |
5.3% |
| Thrombocytopenia |
5.3% |
| Toxicity To Various Agents |
4.3% |
| Condition Aggravated |
3.2% |
| Fall |
3.2% |
| Mania |
3.2% |
| Sweat Gland Disorder |
3.2% |
| Atonic Seizures |
2.1% |
| Drug Interaction |
2.1% |
| Drug Intolerance |
2.1% |
| Fatigue |
2.1% |
| Hepatotoxicity |
2.1% |
| Incorrect Dose Administered |
2.1% |
| Intestinal Malrotation |
2.1% |
|
| Interacting |
| Convulsion Prophylaxis |
72.7% |
| Drug Use For Unknown Indication |
18.2% |
| Product Used For Unknown Indication |
9.1% |
|
| Sweat Gland Disorder |
75.0% |
| Drug Interaction |
25.0% |
|
